Latest news from Henogen Products

01/12/2005 : Read our "Success-Story" on the IRC Network Site (Innovation Relay Centres).

13/12/2004 : Henogen Strengthens its Transplantation Products Pipeline by Acquiring IMMUNOTOKO BV

16/09/2004 : Inauguration on September the 16th, by a nice and sunny day, see the pictures

13/09/2004 : Inauguration on September the 16th of its Seneffe-based, newly built, GMP facility (Inauguration Program)

05/11/2002 : Orphan Drug designation of Henogen's vaccinal product

The European Commission granted to Henogen the Orphan Drug Designation for an Epstein-Barr viral glycoprotein, to be used in the prevention of post-transplantation lympho-proliferative disorders.